The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
Clinical trial NCT06176911 · UNKNOWN
Trial details
- NCT number
- NCT06176911
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-05
- Primary completion
- 2024-12-30
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.